載入...

Profiling of three H3F3A-mutated and denosumab-treated giant cell tumors of bone points to diverging pathways during progression and malignant transformation

Giant cell tumor of bone (GCTB) is a locally aggressive lesion of intermediate malignancy. Malignant transformation of GCTB is a rare event. In 2013, the humanized monoclonal antibody against receptor activator of nuclear factor-κb-Ligand (RANKL) denosumab was approved for treatment of advanced GCTB...

全面介紹

Na minha lista:
書目詳細資料
發表在:Sci Rep
Main Authors: Hasenfratz, Marc, Mellert, Kevin, Marienfeld, Ralf, von Baer, Alexandra, Schultheiss, Markus, Roitman, P. D., Aponte-Tinao, L. A., Lehner, Burkhard, Möller, Peter, Mechtersheimer, Gunhild, Barth, Thomas F. E.
格式: Artigo
語言:Inglês
出版: Nature Publishing Group UK 2021
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7952552/
https://ncbi.nlm.nih.gov/pubmed/33707617
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-85319-x
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!